Shu Zheng

发表

Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer

Yanmei Yang, Wangxiong Hu, Kailai Wang, 2022, OncoTargets and therapy.

Oncotargets and Therapy Dovepress Effective Treatment with Icotinib in Lung Adenocarcinoma with Egfr and Alk Co-alterations and Brain Metastasis

Ji Wang, Chenyang Ye, Y. Chai, 2022 .

COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management

Ji Wang, Chenyang Ye, Lina Qi, 2021, Frontiers in Medicine.

Circulating tumor cells: biology and clinical significance

Yiding Chen, Jiaojiao Zhou, Qi Yang, 2021, Signal Transduction and Targeted Therapy.

Special Issues Encountered When Cancer Patients Confront COVID-19

Chenyang Ye, Lina Qi, Kailai Wang, 2020, Frontiers in Oncology.

DNA methylation in the tumor microenvironment

Lei Zheng, Xu Che, Shu Zheng, 2017, Journal of Zhejiang University-SCIENCE B.

Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2

Yiding Chen, Jiaojiao Zhou, Yunxiang Zhou, 2022, npj Breast Cancer.

Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA.

D. Cui, Lifeng Qi, H. Fu, 2012, Biomacromolecules.

miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4.

Huawei Jiang, Xibin Xiao, Wangxiong Hu, 2023, Omics : a journal of integrative biology.